Synthesis, radiolabeling and biodistribution of morphine glucuronide (mor-glu)
- 152 Downloads
The aim of this study was to synthesize a glucuronide conjugated morphine derivative which could be labeled with 131I, as a radiopharmaceutical, and to investigate its radiopharmaceutical potential using biodistribution studies in male Albino Wistar rats. Morphine was extracted from dry capsules of the opium poppy (Papaver somniferum L.). It was conjugated with UDP-glucuronic acid by using UDP-glucuronyl transferase (UDPGT) enzyme rich microsomes, purified by high performance liquid chromatography (HPLC) and characterized by nuclear magnetic resonance (NMR), infrared (IR) spectroscopy and liquid chromatography mass spectroscopy (LC-MS/MS). Normal and receptor blockage biodistribution studies were performed in male Albino Wistar rats. The results of the tissue distribution studies showed that 131I labeled morphine glucuronide (131I-mor-glu) uptake in the small intestine, large intestine and urinary bladder was higher than in the other tissues of the rats in the blocked receptor and unblocked receptor. A greater uptake of the radio labeled substance was observed in the hypothalamus and mid brain than in the other branches of the rats’ brains.
KeywordsMorphine glucuronide Radiolabeling 131I Biodistribution 131I labeled morphine-glucuronide (131I-mor-glu)
The authors thank for the financial supports from The Scientific and Technical Research Council of Turkey (TUBITAK, Project number 2004-104T187) and T.R Prime Ministry State Planning Organization (DPT, Project Number 2006 DPT 06).
- 1.Hoffman B (2009) Socio-cultural transformation and drug dependence in youth. Trakia J Sci 7(3):21–28Google Scholar
- 3.Goumon Y, Laux A, Muller A, Aunis D (2009) Central and peripheral endogenous morphine. An R Acad Nac Farm 75(3):389–418Google Scholar
- 5.Van Ree JM, Gerrits MA, Vanderschuren LJ (1999) Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol Rev 51(2):341–396Google Scholar
- 14.Enginar H, Ünak P, Biber Müftüler FZ, Yurt-Lambrecht F, Medine EI, Yolcular S, Yurt A, Seyitoğlu B, Bulduk I (2009) Synthesis, radiolabeling and in vivo tissue distribution of codeine-glucuronide. INCS News 22(6–2):46–56Google Scholar
- 18.Muftuler FZ, Unak P, Yolcular S, Kilcar AY, Ichedef C, Enginar H, Sakarya S (2010) Synthesis, radiolabeling and in vivo tissue distribution of an anti-oestrogen glucuronide compound, 99mTc-TOR-G. Anticancer Res 30(4):1243–1249Google Scholar
- 23.Smith HS (2009) Opioid metabolism. Mayo Clin Proc 84(7):613–624Google Scholar
- 24.Fries DS (1995) Analgesics in principles of medicinal chemistry. Williams & Wilkins Media, PhiladelphiaGoogle Scholar
- 25.Gutstein HB, Akil H (2001) Opioid analgesics in the pharmacological basis of therapeutics. Mcgraw-Hill, New YorkGoogle Scholar
- 26.Rice KC (1985) The development of a practical total synthesis of natural and unnatural codeine, morphine and thebaine. Springer-Verlag, BerlinGoogle Scholar
- 27.Ishikawa K, Shibanoki S, McGaugh JL (1983) Direct correlation between level of morphine and its biochemical effect on monoamine systems in mouse brain. Evidence for involvement of dopaminergic neurons in the pharmacological action of acute morphine. Biochem Pharmacol 32(9):1473–1478CrossRefGoogle Scholar